You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

XPOVIO

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Small Cell Lung Carcinoma (NSCLC), Colorectal Cancer (CRC), Other Solid Tumors Trial in Israel (Selinexor 100 mg, Docetaxel,

Recruiting
  • Non-Small Cell Lung Carcinoma (NSCLC)
  • +2 more
  • Selinexor 100 mg
  • +6 more
  • Ashdod, Israel
  • +10 more
Jan 30, 2023

Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)

Not yet recruiting
  • Ovarian Cancer
  • Maywood, Illinois
    Loyola University Medical Center
Aug 1, 2023

Coronavirus Infection Trial (Selinexor)

Withdrawn
  • Coronavirus Infection
  • (no location specified)
Jan 19, 2023

Hepatocellular Carcinoma Trial in Tampa (Selinexor Pill, Bevacizumab, Atezolizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Selinexor Pill
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Aug 16, 2022

Metastatic Colorectal Cancer Trial in Los Angeles, Newark, Plantation (Selinexor, Pembrolizumab, Trifluridine)

Terminated
  • Metastatic Colorectal Cancer
  • Los Angeles, California
  • +2 more
Jan 24, 2023

Multiple Myeloma Trial in Guangzhou (Selinexor, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Guangzhou, Guangdong, China
  • +3 more
Aug 16, 2022

Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Leiomyosarcoma Trial in Toronto (Selinexor)

Recruiting
  • Soft Tissue Sarcoma
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 7, 2022

Recurrent Histiocytic and Dendritic Cell Tumor, Recurrent Non-Hodgkin Lymphoma, Refractory Histiocytic and Dendritic Cell Tumor

Recruiting
  • Recurrent Histiocytic and Dendritic Cell Neoplasm
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 5, 2022

Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento

Recruiting
  • Advanced Urothelial Carcinoma
  • +3 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jun 28, 2022

MGMT-Methylated Glioblastoma, Recurrent Glioblastoma, IDH-Wildtype Trial (Selinexor, Temozolomide)

Not yet recruiting
  • MGMT-Methylated Glioblastoma
  • Recurrent Glioblastoma, IDH-Wildtype
  • (no location specified)
Jun 28, 2022

DLBCL Germinal Center B-Cell Type Trial in China (Selinexor, Rituximab, Cyclophosphamide)

Recruiting
  • DLBCL Germinal Center B-Cell Type
  • Guangzhou, Guangdong, China
  • +5 more
Aug 16, 2022

Multiple Myeloma Trial in Denmark, Estonia, Norway (Selinexor 20 MG Oral Tablet, Bortezomib Injection, Lenalidomide capsule)

Recruiting
  • Multiple Myeloma
  • Selinexor 20 MG Oral Tablet
  • +3 more
  • Aalborg, Denmark
  • +10 more
Apr 22, 2022

Advanced Alveolar Soft Part Sarcoma, Advanced Soft Tissue Sarcoma, Metastatic Alveolar Soft Part Sarcoma Trial run by the NCI

Recruiting
  • Advanced Alveolar Soft Part Sarcoma
  • +3 more
  • Atezolizumab
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jan 28, 2023

Locally Advanced Unresectable or Metastatic Melanoma Trial in United States (Selinexor, Pembrolizumab)

Recruiting
  • Locally Advanced Unresectable or Metastatic Melanoma
  • Los Angeles, California
  • +12 more
Jun 30, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in

Suspended
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +2 more
  • gemcitabine hydrochloride
  • +4 more
  • Detroit, Michigan
  • +1 more
Feb 2, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Carfilzomib, Dexamethasone, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 3, 2022

Multiple Myeloma, Myeloma Multiple, Kahler Disease Trial in United States (Selinexor, Dexamethasone Oral, Daratumumab)

Recruiting
  • Multiple Myeloma
  • +6 more
  • Tucson, Arizona
  • +9 more
Jan 5, 2022

Multiple Myeloma, Refractory Trial in Greece, Israel (Selinexor, Dexamethasone, Bortezomib)

Recruiting
  • Multiple Myeloma, Refractory
  • Patra, Achaia, Greece
  • +15 more
Apr 4, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Des Moines, Iowa
  • +8 more
Jan 12, 2023

Ovarian Carcinoma, Endometrial Carcinoma, Cervical Carcinoma Trial in Belgium, Denmark (Selinexor)

Completed
Has Results
  • Ovarian Carcinoma
  • +2 more
  • Leuven, Belgium
  • +3 more
Jan 13, 2021

Solid Tumor Trial in Canada, Denmark, United States (Selinexor, Acetaminophen)

Completed
Has Results
  • Solid Tumor
  • Tampa, Florida
  • +5 more
Apr 6, 2021

Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)

Recruiting
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +17 more
Apr 1, 2022

Relapsed Refractory Multiple Myeloma Trial in United States (Abemaciclib, dexamethasone, ixazomib, pomalidomide, Enasidenib,

Recruiting
  • Relapsed Refractory Multiple Myeloma
  • Abemaciclib, dexamethasone, ixazomib, pomalidomide
  • +7 more
  • Phoenix, Arizona
  • +16 more
Sep 9, 2021

Coronavirus Infection Trial in Worldwide (Selinexor, Placebo)

Completed
Has Results
  • Coronavirus Infection
  • Los Angeles, California
  • +32 more
Oct 27, 2021

Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Conroe, Texas
  • +4 more
Dec 5, 2022